2025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. None of the reviewed studies would change the direction or strength of the existing guideline recommendations.”
Read the full article here.
A comprehensive review of recent literature assessed whether updates are needed for the ASH ISTH NHF WFH 2021 guidelines on the diagnosis and management of von Willebrand disease (VWD).
Of 432 studies screened for diagnosis and 288 for management, a subset underwent full text review, but none provided evidence strong enough to alter the current recommendations in direction or strength.
As VWD remains the most common inherited bleeding disorder, continued monitoring of emerging data is planned to ensure the guidelines remain current and evidence-based.
Find latest scientific updates on von Willebrand disease featured in Hemostasis Today.
-
Aug 19, 2026, 01:43Elvira Grandone: Cancer and Thrombosis in Women – Where Do We Stand?
-
Aug 19, 2026, 01:37Ifeanyichukwu Ifechidere: Coagulation Knowledge – A Core Skill in Internal Medicine
-
Aug 19, 2026, 01:34Tommy Alfaro Moya: Celebrating a New Chapter Contribution in Clinical Hematology and Hemato-Oncology
-
Aug 19, 2026, 01:29Axay Tomar: Precision Transfusion and Optimizing Blood Component Therapy in Hematology
-
Aug 19, 2026, 01:21Navigating the Unpredictability of Factor VII Deficiency – EHC
-
Aug 18, 2026, 19:49Make the Most of Your Summer and Catch Up on Gene Therapy – EAHAD
-
Aug 18, 2026, 19:46Lesley Van Wyk: ANA Testing – From Screening to Interpretation
-
Aug 18, 2026, 19:45Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
-
Aug 18, 2026, 19:42Melanie Jay: What Should Behavioral Support Look Like Alongside Obesity Medications?